Retrospective Evaluation of Real-World Treatment Patterns in Patients with Mantle Cell Lymphoma - REALM in a Single Brazilian Center

被引：0
|
作者：
Bellesso, Marcelo [1 ]
Santucci, Rodrigo [1 ]
Centrone, Renato Torrescasana [1 ]
Dias, Daniela Ferreira [1 ]
Rodrigues, Mariana Nascimento Caiaffo [1 ]
Travassos, Luana Correa [1 ]
Oliveira, Iohana Gabriely Costa [1 ]
Gomes, Tamyres Alves [1 ]
Espadas, Caroline Jorge [1 ]
Ferreira, Joyce Barreto Marques da Rosa [1 ]
Santucci, Bruno [1 ]
Alves, Adelson [1 ]
机构：
[1] Inst Ensino & Pesquisa Sao Lucas IEP Hemomed, Sao Paulo, SP, Brazil
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-164590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11972 / 11973
页数：2
相关论文
共 50 条
  • [21] Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma
    Patel, Krish
    Teschemaker, Anna
    Tian, Hongping
    Pyrih, Nick
    Kolvenbag, Geert
    Patel, Shweta
    Wahlstrom, Svea K.
    Cui, Lianzhou
    BLOOD, 2024, 144 : 7745 - 7745
  • [22] Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: A population-based analyses.
    Di, Mengyang
    Long, Jessica B.
    Kothari, Shalin
    Sethi, Tarsheen Kaur
    Zeidan, Amer Methqal
    Podoltsev, Nikolai Alexandrovich
    Shallis, Rory
    Wang, Rong
    Ma, Xiaomei
    Huntington, Scott F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Real-World Bruton Tyrosine Kinase Inhibitor Treatment Patterns, Compliance, Costs, and Hospitalizations in Patients with Mantle Cell Lymphoma in the United States
    Shah, Bijal D.
    Yang, Keri
    Liu, Sizhu
    Sivanantham, Jai
    Ali, Yasser
    Casten, Chris
    Satya, Swaroop
    Tang, Boxiong
    BLOOD, 2021, 138
  • [24] Real-World Evidence of Brexucabtagene Autoleucel for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Camacho, Lina
    Chiappella, Annalisa
    Guadagnuolo, Serafina
    Lopez Corral, Lucia
    Bastos-Oreiro, Mariana
    Delgado Serrano, Javier
    Schmidt, Christian
    Carpio, Cecilia
    Luis Reguera, Juan
    Kwon, Mi
    Martin Garcia-Sancho, Alejandro
    Luigi Zinzani, Pier
    Corradini, Paolo
    Subklewe, Marion
    Barba, Pere
    BLOOD, 2021, 138
  • [25] Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Villacampa, Guillermo
    van Doesum, Jaap A.
    Chiappella, Annalisa
    Bonifazi, Francesca
    Lopez-Corral, Lucia
    van Aalderen, Michiel
    Kwon, Mi
    Martinez-Cibrian, Nuria
    Bramanti, Stefania
    Luis Reguera-Ortega, Juan
    Camacho-Arteaga, Lina
    Schmidt, Christian
    Marin-Niebla, Ana
    Jose Kersten, Marie
    Martin Garcia-Sancho, Alejandro
    Zinzani, Pier Luigi
    Corradini, Paolo
    van Meerten, Tom
    Subklewe, Marion
    Barba, Pere
    BLOOD ADVANCES, 2022, 6 (12) : 3606 - 3610
  • [26] Treatment Patterns Among Patients With Mantle Cell Lymphoma and Comparison of Healthcare Resource Utilization and Costs Among Relapsed/Refractory Patients Treated With Ibrutinib or Chemoimmunotherapy: A Real-world Retrospective Study
    Ghosh, Nilanjan
    Emond, Bruno
    Lafeuille, Marie-Helene
    Cote-Sergent, Aurelie
    Lefebvre, Patrick
    Huang, Qing
    CLINICAL THERAPEUTICS, 2021, 43 (08) : 1285 - 1299
  • [27] Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
    Yi, Jun Ho
    Kim, Seok Jin
    Yoon, Dok Hyun
    Suh, Cheolwon
    Chang, Myung Hee
    Yang, Deok Hwan
    Jo, Jae-Cheol
    Hyun, Shin Young
    Eom, Hyeon-Seok
    Lee, Jeong-Ok
    Kwon, Ji Hyun
    Han, Sang Hoon
    Lee, Seung-Shin
    Kwak, Jae-Yong
    Kim, Se Hyung
    Kim, Dae Sik
    Lee, Ji Hyun
    Oh, Sung Yong
    Ryoo, Hun Mo
    Kim, Hyo Jung
    Kim, Won Seog
    CANCER COMMUNICATIONS, 2021, 41 (03) : 275 - 278
  • [28] Outcomes of Patients with Primary Refractory Mantle Cell Lymphoma, a Single Center Retrospective Study
    Bond, David A.
    Huang, Ying
    Christian, Beth
    Maddocks, Kami J.
    BLOOD, 2017, 130
  • [29] MANTLE CELL LYMPHOMA MAY HAVE A DIFFERENT CLINICAL COURSE IN MEXICAN MESTIZOS: REAL-WORLD DATA FROM A SINGLE CENTER
    Cordova-Ramirez, Alejandra C.
    Sanchez-Valledor, Luisa F.
    Colon-Otero, Gerardo
    Rivera-Alvarez, Montserrat
    Elias-de-la-Cruz, Gilberto D.
    Murrieta-Alvarez, Ivan
    Cantero-Fortiz, Yahveth
    Leon-Pena, Andres
    Olivares-Gazca, Juan C.
    Ruiz-Delgado, Guillermo J.
    Ruiz-Arguelles, Guillermo J.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (02): : 94 - 99
  • [30] MANTLE CELL LYMPHOMA (MCL): A RETROSPECTIVE STUDY OF 76 PATIENTS FROM A SINGLE CENTER
    Vilaseca Marta, Canelo
    Calduch Olga, Garcia
    Tomas Marc, Sorigue
    Melendo Gustavo, Tapia
    Tapiador Rebeca, Jurado
    Tesas Alejandro, De Jaureguizar
    Sarto Mireia, Franch
    Velazquez Miriam, Moreno
    Magan Alicia, Senin
    Sabater Laura, Abril
    Fernandez Gladys, Ibarra
    Jose Tomas, Navarro Ferrando
    Josep Maria, Ribera Santasusana
    Juan Manuel, Sancho Cia
    HAEMATOLOGICA, 2021, 106 (10) : 302 - 303
12345